Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
3 citing papers in PubMed, 5 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
5 authors at 1 institution in 1 country.
William LoryDepartment of Oral Health Sciences, College of Dental Medicine, Medical University of South Carolina, Charleston, SC 29425, USA.
Bridgette WellslagerDepartment of Oral Health Sciences, College of Dental Medicine, Medical University of South Carolina, Charleston, SC 29425, USA.
Chao SunDivision of Laboratory Animal Resources, Medical University of South Carolina, Charleston, SC 29425, USA.
Özlem YilmazDepartment of Oral Health Sciences, College of Dental Medicine, Medical University of South Carolina, Charleston, SC 29425, USA.ORCID 0000-0003-3487-7217
Hong YuDepartment of Oral Health Sciences, College of Dental Medicine, Medical University of South Carolina, Charleston, SC 29425, USA.ORCID 0000-0002-0930-6810
Medical University of South Carolina · US
Funding
South Carolina Clinical & Translational Research Institute (SCTR)UL1TR001450 · NCATS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T., FLUME, PATRICK A · 2015 to 2024
$41.1M
Turning on Persistence: Novel Molecular Determinants that Underpin P. gingivalis' Intracellular Survival In Epithelial CellsR01DE030313 · NIDCR · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI YILMAZ, OZLEM · 2020 to 2024
$2.3M
Targeting sphingosine-1-phosphate receptor 2 as a novel therapeutic strategy for periodontitisR15DE027324 · NIDCR · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI YU, HONG · 2018 to 2018
$437k
Role of sphingosine-1-phosphate receptor 2 in osteoblastogenesis and bone regeneration in periodontitisR21DE030865 · NIDCR · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI YU, HONG · 2021 to 2022
$415k
The Role of Glutamine Metabolism for P. gingivalis-Induced Non-Canonical Autophagy in Epithelial CellsF31DE032273 · NIDCR · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI WELLSLAGER, BRIDGETTE FRANCES · 2022 to 2023
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Inhibition of Sphingosine-1-Phosphate Receptor 2 by JTE013 Enhanced Alveolar Bone Regeneration by Promoting Angiogenesis. · full record | OpenQuestion